Q1 2025 Management View CEO Reshma Kewalramani highlighted $2.77 billion in revenue for Q1 2025, reflecting 3% growth ...

Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a ...

Vertex Pharmaceuticals Inc. said more than 20,000 prescriptions have been dispensed for its new non-addictive painkiller, a sign that the drug is gaining some early traction as it attempts to displace ...

An Iowa nurse who was allowed to keep her license under an agreement approved by the Iowa Board of Nursing last month is now ...

Agents that target NaV1.8, a voltage-gated sodium channel, are showing promise. The FDA approved one of them, Journavx ...

The money has gone to residential treatment program scholarships, mental health liaisons in police departments, and a recovery center in Alfred.

Gene therapy and mindfulness training show promise for America's epidemic of chronic pain. Can they provide the relief of opioid medication without side effects and addiction?

A new street drug called Xalyzine, an animal sedative, is being used to coat fentanyl and make its effects last longer, ...

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of ...

Opioid addiction can happen to anyone and is a significant public health issue. Taking proper precautions can reduce your ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.